Iceland vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy
Iceland
0 patients
in 2014
Montserrat
0 patients
in 2019
Iceland rank
141st
Montserrat rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Iceland
- Montserrat
How they compare
Iceland currently reports 0 patients against 0 patients in Montserrat, a difference of 0 patients.
The two have swapped places 2 times across 8 shared years of data; in 2003 it was Montserrat ahead.
Iceland ranks 141st and Montserrat ranks 141st of 183 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Montserrat | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.75 patients | 0.5 patients | 0.25 patients | Iceland |
| 2010s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Iceland or Montserrat?
- Iceland, at 0 patients against 0 patients in Montserrat as of 2014.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Iceland and Montserrat?
- 0 patients, with Iceland ahead.
- How many years of comparable data are there for Iceland and Montserrat?
- 8 years are reported by both, from 2003 to 2013.
- How do Iceland and Montserrat rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Iceland ranks 141st and Montserrat ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.